Treatment of common warts with an intralesional mixture of 5-fluorouracil, lidocaine, and epinephrine: A prospective placebo-controlled, double-blind randomized trial

Dermatologic Surgery

Volumn 34, Issue 5, 2008, Pages 656-659

  Yazdanfar, Ameneh ^a   Farshchian, Mahmood ^a   Fereydoonnejad, Morteza ^a   Farshchian, Mehdi ^a  

^a Sina Hospital Hamedan   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FLUOROURACIL; LIDOCAINE; PLACEBO; SODIUM CHLORIDE; ANTIMETABOLITE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; MALE; NECROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCAR FORMATION; TREATMENT RESPONSE; ULCER; VERRUCA VULGARIS; DRUG COMBINATION; INTRALESIONAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMETABOLITES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPINEPHRINE; FEMALE; FLUOROURACIL; HUMANS; INJECTIONS, INTRALESIONAL; LIDOCAINE; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WARTS;

EID: 42449164573     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.34123.x     Document Type: Article

References (19)

1. Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990 22:547 66.
2. Laurent R, Kienzler JL. Epidemiology of HPV infections. Clin Dermatol 1985 3:64 70.
3. Zamanian A, Mahjub H. Prevalence of skin diseases in Hamedan in the west of Iran in 2002. Indian J Dermatol 2005 50:208 11.
4. Bunney MH, Nolan MW, Williams DA. An assessment of methods of treating viral warts by comparative treatment trials based on a standard design. Br J Dermatol 1976 94:667 79.
5. Gibbs RC, Scheiner AM. Long-term follow-up evaluation of patients with electrosurgically treated warts. Cutis 1978 21:383 4.
6. Shumer SM, O'Keefe EJ. Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol 1983 9:91 6.
7. Street ML, Roenigk RK. Recalcitrant periungual verrucae: the role of carbon dioxide laser vaporization. J Am Acad Dermatol 1990 23:115 20.
8. Lim JT, Goh CL. Carbon dioxide laser treatment of periungual and subungual viral warts. Aust J Dermatol 1992 33:87 91.
9. Sterling JC, Handfield-Jones S, Hudson PM. British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol 2001 144:4 11.
10. Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ 2002 325:461.
11. Myles PS, Troedel S, Boquest M, et al. The pain visual analog scale: is it linear or nonlinear? Anesth Analg 1999 89:1517 20.
12. Ghoshal K, Jacob ST. An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug. Biochem Pharmacol 1997 53:1569 75.
13. Bunney MH. The treatment of plantar warts with 5-fluorouracil. Br J Dermatol 1973 89:96 7.
14. Hursthouse MW. A controlled trial on the use of topical 5-fluorouracil on viral warts. Br J Dermatol 1975 92:93 6.
15. Schmidt H, Jacobsen FK. Double-blind randomized clinical study on treatment of warts with a fluorouracil-containing topical preparation (author's transl). Z Hautkr 1981 56:41 3.
16. Beers MH, Berkow R, editors. The Merck manual of diagnosis and therapy hematology and oncology. West Point (PA):Merck 1999. p. 990.
17. Iscimen A, Aydemir EH, Goksugur N, et al. Intralesional 5-fluorouracil, lidocaine and epinephrine mixture for the treatment of verrucae: a prospective placebo-controlled, single-blind randomized study. J Eur Acad Dermatol Venereol 2004 18:455 8.
18. Swinehart JM, Sperling M, Phillips S, et al. Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata. A phase 3 clinical study. Arch Dermatol 1997 133:67 73.
19. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol 2005 52:474 9.